×

Glucose sensor health monitoring and related methods and systems

  • US 10,152,049 B2
  • Filed: 05/19/2014
  • Issued: 12/11/2018
  • Est. Priority Date: 05/19/2014
  • Status: Active Grant
First Claim
Patent Images

1. A method of providing indication when replacement of an interstitial glucose sensing element of a sensing arrangement should be performed in connection with operating an infusion device operable to deliver fluid to a user based on measurements indicative of an interstitial fluid glucose level of the user provided by the sensing arrangement, the fluid influencing the physiological condition of the user, the method comprising:

  • obtaining, by a control module coupled to the interstitial glucose sensing element of the sensing arrangement, a plurality of uncalibrated measurements corresponding to a monitoring period based on output signals provided by the sensing element, wherein the output signals are influenced by the interstitial fluid glucose level of the user;

    obtaining, by the control module, a calibration factor for converting the plurality of uncalibrated measurements to a plurality of calibrated measurement values for the physiological condition;

    for each respective measurement of the plurality of uncalibrated measurements;

    determining a second derivative metric associated with the respective measurement based at least in part on a difference between a first derivative metric associated with the respective measurement and the first derivative metric associated with the preceding measurement of the plurality of uncalibrated measurements, wherein the second derivative metric associated with a most recent measurement of the plurality of uncalibrated measurements comprises the greater of a difference between the first derivative metric associated with the most recent measurement and the first derivative metric associated with the immediately preceding measurement of the plurality of uncalibrated measurements and an average magnitude of second derivative metric values associated with the plurality of uncalibrated measurements; and

    scaling the second derivative metric associated with the respective measurement by the calibration factor to determine a noise metric for the respective measurement of the plurality of uncalibrated measurements;

    determining, by the control module, a number of high noise measurements for the monitoring period based on the noise metrics for the respective measurements of the plurality of uncalibrated measurements;

    determining, by the control module, an output measurement value indicative of the interstitial fluid glucose level based at least in part on the most recent measurement of the plurality of uncalibrated measurements and at least one of the first derivative metric associated with the most recent measurement and the second derivative metric associated with the most recent measurement;

    transmitting, by a communications interface coupled to the control module, the output measurement value to the infusion device, wherein a delivery command for operating a motor of the infusion device to autonomously control delivery of the fluid to the user is determined based at least in part on the output measurement value and the calibration factor; and

    providing, via an output interface of the sensing arrangement, indication replacement of the interstitial glucose sensing element should be performed when a reliability metric influenced by the number of high noise measurements violates a first threshold.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×